Targeting NO/cGMP Signaling in the CNS for Neurodegeneration and Alzheimer's Disease
- PMID: 27776476
- DOI: 10.2174/0929867323666160812145454
Targeting NO/cGMP Signaling in the CNS for Neurodegeneration and Alzheimer's Disease
Abstract
cAMP-response element-binding protein (CREB) plays a central role in various aspects of central nervous system (CNS) function, ranging from the developmental stages to neuronal plasticity and survival in adult brain. Activation of CREB plays a crucial role in learning and memory and is at the convergence of multiple intracellular signaling cascades including CAMKII and MAPK. This review focuses on the important functions of nitric oxide (NO) in activating CREB via the NO receptor, soluble guanylyl cyclase (sGC), and production of the second messenger, cGMP. The involvement of the NO/cGMP signaling pathway in synaptic plasticity suggests several avenues for therapeutic intervention, and targeting early synaptic degeneration could be an attractive approach for the development of novel disease-modifying approaches to treat cognition and memory dysfunction in neurodegenerative diseases.
Similar articles
-
Modulating nitric oxide signaling in the CNS for Alzheimer's disease therapy.Future Med Chem. 2013 Aug;5(12):1451-68. doi: 10.4155/fmc.13.111. Future Med Chem. 2013. PMID: 23919554 Review.
-
Amyloid-beta peptide inhibits activation of the nitric oxide/cGMP/cAMP-responsive element-binding protein pathway during hippocampal synaptic plasticity.J Neurosci. 2005 Jul 20;25(29):6887-97. doi: 10.1523/JNEUROSCI.5291-04.2005. J Neurosci. 2005. PMID: 16033898 Free PMC article.
-
Cyclic GMP and nitric oxide synthase in aging and Alzheimer's disease.Mol Neurobiol. 2010 Jun;41(2-3):129-37. doi: 10.1007/s12035-010-8104-x. Epub 2010 Mar 9. Mol Neurobiol. 2010. PMID: 20213343 Review.
-
Involvement of the nitric oxide pathway in synaptic dysfunction following amyloid elevation in Alzheimer's disease.Rev Neurosci. 2006;17(5):497-523. doi: 10.1515/revneuro.2006.17.5.497. Rev Neurosci. 2006. PMID: 17180876 Review.
-
The CNS-penetrant soluble guanylate cyclase stimulator CYR119 attenuates markers of inflammation in the central nervous system.J Neuroinflammation. 2021 Sep 18;18(1):213. doi: 10.1186/s12974-021-02275-z. J Neuroinflammation. 2021. PMID: 34537066 Free PMC article.
Cited by
-
The CNS-Penetrant Soluble Guanylate Cyclase Stimulator CY6463 Reveals its Therapeutic Potential in Neurodegenerative Diseases.Front Pharmacol. 2021 May 24;12:656561. doi: 10.3389/fphar.2021.656561. eCollection 2021. Front Pharmacol. 2021. PMID: 34108877 Free PMC article.
-
cAMP Response Element-Binding Protein (CREB): A Possible Signaling Molecule Link in the Pathophysiology of Schizophrenia.Front Mol Neurosci. 2018 Aug 30;11:255. doi: 10.3389/fnmol.2018.00255. eCollection 2018. Front Mol Neurosci. 2018. PMID: 30214393 Free PMC article. Review.
-
Preparation, Antioxidant Properties and Ability to Increase Intracellular NO of a New Pyridoxine Derivative B6NO.Antioxidants (Basel). 2021 Sep 13;10(9):1451. doi: 10.3390/antiox10091451. Antioxidants (Basel). 2021. PMID: 34573083 Free PMC article.
-
Vitamins in the Prevention and Support Therapy of Neurodegenerative Diseases.Int J Mol Sci. 2025 Feb 4;26(3):1333. doi: 10.3390/ijms26031333. Int J Mol Sci. 2025. PMID: 39941101 Free PMC article. Review.
-
Therapeutic Potential of Phosphodiesterase Inhibitors against Neurodegeneration: The Perspective of the Medicinal Chemist.ACS Chem Neurosci. 2020 Jun 17;11(12):1726-1739. doi: 10.1021/acschemneuro.0c00244. Epub 2020 May 28. ACS Chem Neurosci. 2020. PMID: 32401481 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical